How a Danish Company Grabbed Control of the Monkeypox Vaccine

German government science and American public money underpinned the development of Jynneos, but one Danish company now controls it entirely.

by

The American Prospect is nonprofit, reader-funded journalism—and we need your help.

Our reporters dig deep, hold power to account, and explain how policy shapes people’s lives. If you value independent journalism that goes beyond the headlines, now’s the time to support it.

Here’s how you can help:
Donate to power fearless reporting
Subscribe to get our print magazine 6x/year. 

Every dollar funds our in-depth reporting. 


Donate Now. Subscribe here.